These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17940974)

  • 1. In vitro evaluation of antisense RNA efficacy against filovirus infection, by use of reverse genetics.
    Groseth A; Hoenen T; Alimonti JB; Zielecki F; Ebihara H; Theriault S; Ströher U; Becker S; Feldmann H
    J Infect Dis; 2007 Nov; 196 Suppl 2():S382-9. PubMed ID: 17940974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel program to design siRNAs simultaneously effective to highly variable virus genomes.
    Lee HS; Ahn J; Jun EJ; Yang S; Joo CH; Kim YK; Lee H
    Biochem Biophys Res Commun; 2009 Jul; 384(4):431-5. PubMed ID: 19422797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human metapneumovirus replication by small interfering RNA.
    Deffrasnes C; Cavanagh MH; Goyette N; Cui K; Ge Q; Seth S; Templin MV; Quay SC; Johnson PH; Boivin G
    Antivir Ther; 2008; 13(6):821-32. PubMed ID: 18839783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and sequence motifs of siRNA linked with in vitro down-regulation of morbillivirus gene expression.
    de Almeida RS; Keita D; Libeau G; Albina E
    Antiviral Res; 2008 Jul; 79(1):37-48. PubMed ID: 18394725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective siRNA targeting of the 3' untranslated region of the West Nile virus genome.
    Anthony KG; Bai F; Krishnan MN; Fikrig E; Koski RA
    Antiviral Res; 2009 Jun; 82(3):166-8. PubMed ID: 19135091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal design and validation of antiviral siRNA for targeting hepatitis B virus.
    Fu J; Tang ZM; Gao X; Zhao F; Zhong H; Wen MR; Sun X; Song HF; Qian XH
    Acta Pharmacol Sin; 2008 Dec; 29(12):1522-8. PubMed ID: 19026173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA interference mediated inhibition of Chikungunya virus replication in mammalian cells.
    Dash PK; Tiwari M; Santhosh SR; Parida M; Lakshmana Rao PV
    Biochem Biophys Res Commun; 2008 Nov; 376(4):718-22. PubMed ID: 18805396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of small-interfering RNAs.
    de Jonge J; Holtrop M; Wilschut J; Huckriede A
    Gene Ther; 2006 Mar; 13(5):400-11. PubMed ID: 16267567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA interference of avian influenza virus H5N1 by inhibiting viral mRNA with siRNA expression plasmids.
    Zhou K; He H; Wu Y; Duan M
    J Biotechnol; 2008 Jun; 135(2):140-4. PubMed ID: 18456361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of interfering RNAs targeted against feline herpesvirus 1 glycoprotein D for inhibition of feline herpesvirus 1 infection of feline kidney cells.
    Wilkes RP; Kania SA
    Am J Vet Res; 2009 Aug; 70(8):1018-25. PubMed ID: 19645584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activity of a small-molecule inhibitor of filovirus infection.
    Warren TK; Warfield KL; Wells J; Enterlein S; Smith M; Ruthel G; Yunus AS; Kinch MS; Goldblatt M; Aman MJ; Bavari S
    Antimicrob Agents Chemother; 2010 May; 54(5):2152-9. PubMed ID: 20211898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of red seabream iridovirus (RSIV) replication by small interfering RNA (siRNA) in a cell culture system.
    Dang LT; Kondo H; Hirono I; Aoki T
    Antiviral Res; 2008 Feb; 77(2):142-9. PubMed ID: 18037509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of reverse genetics systems in determining filovirus pathogenicity.
    Theriault S; Groseth A; Artsob H; Feldmann H
    Arch Virol Suppl; 2005; (19):157-77. PubMed ID: 16355872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein.
    Ebihara H; Theriault S; Neumann G; Alimonti JB; Geisbert JB; Hensley LE; Groseth A; Jones SM; Geisbert TW; Kawaoka Y; Feldmann H
    J Infect Dis; 2007 Nov; 196 Suppl 2():S313-22. PubMed ID: 17940966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rescue of Ebola virus from cDNA using heterologous support proteins.
    Theriault S; Groseth A; Neumann G; Kawaoka Y; Feldmann H
    Virus Res; 2004 Nov; 106(1):43-50. PubMed ID: 15522446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of siRNA on HSV-1 plaque formation and relative expression levels of UL39 mRNA.
    Zhe R; Mei-Ying Z; Kitazato K; Kobayash N; Qin-Chang Z; Pei-Zhuo Z; Zhi-Rong Y; Yi-Fei W
    Arch Virol; 2008; 153(7):1401-6. PubMed ID: 18551244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selecting effective siRNA sequences based on the self-organizing map and statistical techniques.
    Takasaki S; Kawamura Y; Konagaya A
    Comput Biol Chem; 2006 Jun; 30(3):169-78. PubMed ID: 16600687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convenient targeting of stealth siRNA-lipoplexes to cells with chelator lipid-anchored molecules.
    Herringson TP; Altin JG
    J Control Release; 2009 Nov; 139(3):229-38. PubMed ID: 19595724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific inhibition of orthopoxvirus replication by a small interfering RNA targeting the D5R gene.
    Vigne S; Germi R; Duraffour S; Larrat S; Andrei G; Snoeck R; Garin D; Crance JM
    Antivir Ther; 2008; 13(3):357-68. PubMed ID: 18572748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quick identification of effective small interfering RNAs that inhibit the replication of coxsackievirus A16.
    Wu Z; Gao Y; Sun L; Tien P; Jin Q
    Antiviral Res; 2008 Dec; 80(3):295-301. PubMed ID: 18662724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.